Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Upstream Processing

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Fully Human Engineered Bone Niche With Endogenous Osteoclastogenesis Reveals Osteoclast-Dependent Osteomimicry in Prostate Cancer Cells.

Advanced healthcare materials·2026

Same author

Role of external forces in the mechanobiology of stem and differentiated chondrogenic cells embedded in a tissue-engineered construct for cartilage repair.

Journal of biomedical science·2026

Same author

Migration and Chondrogenesis of Cells from Minced Nasal Cartilage in Type I Collagen Hydrogel: A Workflow for One-Step Engineering of Injectable Grafts.

Gels (Basel, Switzerland)·2026

Same author

Modular de- and re-construction of vascularized osteochondral tissues in an Organ-on-Chip dual-compartment platform.

Journal of orthopaedic translation·2026

Same author

A mechanically active nucleus pulposus-on-a-chip for studying mechanobiology and therapeutic strategies in intervertebral disc disease.

Biofabrication·2026

Same author

Start, Stop, Rewind, Repeat-Cyclic Exposure of Adipose Stromal Cells-derived Cartilage Organoids to Chondrogenic and Proliferative Cues to Achieve Scaled-up and Customizable Bone Formation by Endochondral Ossification.

Advanced healthcare materials·2026

Search research articles

Related Experiment Video

Updated: May 1, 2026

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

Manufacturing challenges in regenerative medicine.

Ivan Martin¹, Paul J Simmons, David F Williams

¹Department of Biomedicine, University of Basel, 4031 Basel, Switzerland.

Science Translational Medicine

|April 18, 2014

Summary

Standardizing cell and tissue therapies requires defining manufacturing paradigms to ensure cost-effectiveness and clinical translation. This addresses key challenges beyond scientific and regulatory hurdles for routine patient care.

More Related Videos

Automated Counterflow Centrifugal System for Small-Scale Cell Processing

Automated Counterflow Centrifugal System for Small-Scale Cell Processing

Published on: December 12, 2019

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

Related Experiment Videos

Last Updated: May 1, 2026

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

Automated Counterflow Centrifugal System for Small-Scale Cell Processing

Automated Counterflow Centrifugal System for Small-Scale Cell Processing

Published on: December 12, 2019

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

Area of Science:

Regenerative Medicine
Biotechnology
Clinical Translation

Background:

Cell and tissue therapies offer significant therapeutic potential.
Translating these therapies into routine clinical practice faces multifaceted challenges.
Existing scientific and regulatory hurdles must be overcome.

Purpose of the Study:

To highlight the critical need for standardization in cell and tissue therapy manufacturing.
To emphasize cost-effectiveness as a key factor for clinical adoption.
To define the role of manufacturing paradigms in successful translation.

Main Methods:

Review of current cell and tissue therapy manufacturing approaches.
Analysis of economic factors influencing clinical implementation.
Identification of best practices for scalable production.

Main Results:

Standardization is crucial for consistent therapeutic outcomes.
Cost-effective manufacturing directly impacts accessibility and widespread use.
Defined manufacturing paradigms are essential for regulatory approval and clinical integration.

Conclusions:

Successful translation of cell and tissue therapies hinges on robust standardization and cost-effective manufacturing.
Development of suitable manufacturing paradigms is imperative for routine clinical practice.
Addressing these aspects will accelerate the clinical application of regenerative medicine.